| Radiation dose in nuclear medicine: the hybrid imaging M Salvatori, A Rizzo, G Rovera, L Indovina, O Schillaci La radiologia medica 124, 768-776, 2019 | 39 | 2019 |
| Enhanced recovery pathways in colorectal surgery: a consensus paper by the Associazione Chirurghi Ospedalieri Italiani (ACOI) and the PeriOperative Italian Society (POIS). F Ficari, F Borghi, M Catarci, M Scatizzi, V Alagna, I Bachini, G Baldazzi, ... Il Giornale di Chirurgia 40 (4Supp.), 1-40, 2019 | 26 | 2019 |
| PSMA radioligand uptake as a biomarker of neoangiogenesis in solid tumours: diagnostic or theragnostic factor? A Rizzo, S Dall’Armellina, DA Pizzuto, G Perotti, L Zagaria, V Lanni, ... Cancers 14 (16), 4039, 2022 | 21 | 2022 |
| Activated macrophages are the main inflammatory cell in COVID-19 interstitial pneumonia infiltrates. Is it possible to show their metabolic activity and thus the grade of … G Savelli, M Bonacina, A Rizzo, A Zaniboni Medical Hypotheses 144, 109885, 2020 | 16 | 2020 |
| The role of 18F-FDG PET/CT radiomics in lymphoma A Rizzo, EKA Triumbari, R Gatta, L Boldrini, M Racca, M Mayerhoefer, ... Clinical and Translational Imaging, 1-10, 2021 | 11 | 2021 |
| Potential role of PSMA-targeted PET in thyroid malignant disease: a systematic review A Rizzo, M Racca, S Dall’Armellina, RC Delgado Bolton, D Albano, ... Diagnostics 13 (3), 564, 2023 | 10 | 2023 |
| The emerging role of PET/CT with PSMA-targeting radiopharmaceuticals in clear cell renal cancer: an updated systematic review A Rizzo, M Racca, S Dall’Armellina, P Rescigno, GL Banna, D Albano, ... Cancers 15 (2), 355, 2023 | 10 | 2023 |
| 18F-FDG PET/CT Maximum Tumor Dissemination (Dmax) in Lymphoma: A New Prognostic Factor? D Albano, G Treglia, F Dondi, A Calabrò, A Rizzo, S Annunziata, L Guerra, ... Cancers 15 (9), 2494, 2023 | 7 | 2023 |
| Can PSMA-targeting radiopharmaceuticals be useful for detecting hepatocellular carcinoma using positron emission tomography? An updated systematic review and meta-analysis A Rizzo, M Racca, D Albano, F Dondi, F Bertagna, S Annunziata, ... Pharmaceuticals 15 (11), 1368, 2022 | 7 | 2022 |
| First-line treatment for advanced sclc: What is left behind and beyond chemoimmunotherapy EF Giunta, A Addeo, A Rizzo, GL Banna Frontiers in Medicine 9, 924853, 2022 | 6 | 2022 |
| 18F-FDG PET/CT concurrent with first radioiodine post-therapeutic scan in high risk differentiated thyroid cancer: a useful tool or just an expensive diversion? A Rizzo, G Perotti, L Zagaria, V Lanni, M Racca, N Palestini, M Salvatori The Quarterly Journal of Nuclear Medicine and Molecular Imaging: Official …, 2022 | 5 | 2022 |
| Side effects of theragnostic agents currently employed in clinical practice. A Rizzo, S Annunziata, M Salvatori The Quarterly Journal of Nuclear Medicine and Molecular Imaging: Official …, 2021 | 5 | 2021 |
| The role of theragnostics in breast cancer: A systematic review of the last 12 years M Balma, V Liberini, A Buschiazzo, M Racca, A Rizzo, DG Nicolotti, ... Current medical imaging 19 (8), 817-831, 2023 | 4 | 2023 |
| Diagnostic Performance of Positron Emission Tomography with Fibroblast-Activating Protein Inhibitors in Gastric Cancer: A Systematic Review and Meta-Analysis A Rizzo, M Racca, F Garrou, E Fenocchio, L Pellegrino, D Albano, ... International Journal of Molecular Sciences 24 (12), 10136, 2023 | 4 | 2023 |
| Effects of a video-based preoperative educational intervention plus nurse-led reinforcement discussion on knowledge, self-efficacy, and resilience in patients undergoing major … S Gonella, C Delfino, M Rolfo, A Rizzo, V Esposito, P Berchialla, ... Clinical Nursing Research 30 (6), 753-761, 2021 | 4 | 2021 |
| Penile metastasis from prostate cancer detected by 18F-fluorocholine PET/CT D Bianchi, A Rizzo, M Bonacina, A Zaniboni, G Savelli Clinical Nuclear Medicine 46 (1), e38-e39, 2021 | 4 | 2021 |
| The prognostic role of next-generation imaging-driven upstaging in newly diagnosed prostate cancer patients M Bauckneht, E Checcucci, E Cisero, A Rizzo, M Racca, S De Cillis, ... European Journal of Nuclear Medicine and Molecular Imaging 51 (3), 864-870, 2024 | 3 | 2024 |
| 18F-fluorocholine PET/CT semi-quantitative analysis in patients affected by primary hyperparathyroidism: a comparison between laboratory and functional data A Rizzo, M Racca, S Cauda, M Balma, S Dall’Armellina, B Dionisi, ... Endocrine 80 (2), 433-440, 2023 | 3 | 2023 |
| Factor structure of post-operative quality of recovery questionnaire (QoR-15): An Italian adaptation and validation R Rosato, V Palazzo, F Borghi, M Camanni, A Puppo, EM Delpiano, ... Frontiers in Psychology 13, 1096579, 2023 | 3 | 2023 |
| Diagnostic Accuracy of [68Ga]Ga Labeled Fibroblast-Activation Protein Inhibitors in Detecting Head and Neck Cancer Lesions Using Positron Emission … A Rizzo, A Miceli, M Racca, M Bauckneht, S Morbelli, D Albano, F Dondi, ... Pharmaceuticals 16 (12), 1664, 2023 | 2 | 2023 |
